THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Clash over rules governing biogenerics

November 4, 2008

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

RE " CLEARING the way for low-cost biogenerics " (Op-ed, Oct. 26), whose author, Laurence Kotlikoff, is a paid consultant to one of the largest generics companies in the world: The Massachusetts congressional delegation, under the leadership of healthcare champion Senator Edward Kennedy, is working hard to create the right pathway to biosimilars, or biotechnology generics. At the same time, ... (Full article: 217 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass